Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

Varsha Moudgal, Tania Little, Dina Boikov, Jose A. Vazquez

Research output: Contribution to journalArticle

217 Scopus citations

Abstract

Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)- resistant Candida strain during therapy.

Original languageEnglish (US)
Pages (from-to)767-769
Number of pages3
JournalAntimicrobial agents and chemotherapy
Volume49
Issue number2
DOIs
StatePublished - Feb 1 2005
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis'. Together they form a unique fingerprint.

  • Cite this